BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30041680)

  • 1. Determination of sialic acid in saliva by means of surface-enhanced Raman spectroscopy as a marker in adnexal mass patients: ovarian cancer vs benign cases.
    Zermeño-Nava JJ; Martínez-Martínez MU; Rámirez-de-Ávila AL; Hernández-Arteaga AC; García-Valdivieso MG; Hernández-Cedillo A; José-Yacamán M; Navarro-Contreras HR
    J Ovarian Res; 2018 Jul; 11(1):61. PubMed ID: 30041680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of Salivary Sialic Acid Through Nanotechnology: A Useful Biomarker for the Screening of Breast Cancer.
    Hernández-Arteaga AC; de Jesús Zermeño-Nava J; Martínez-Martínez MU; Hernández-Cedillo A; Ojeda-Galván HJ; José-Yacamán M; Navarro-Contreras HR
    Arch Med Res; 2019 Apr; 50(3):105-110. PubMed ID: 31495386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of sialic acid levels by using surface-enhanced Raman spectroscopy in periodontitis and gingivitis.
    Hernández-Cedillo A; García-Valdivieso MG; Hernández-Arteaga AC; Patiño-Marín N; Vértiz-Hernández ÁA; José-Yacamán M; Navarro-Contreras HR
    Oral Dis; 2019 Sep; 25(6):1627-1633. PubMed ID: 31177594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy and cost-effectiveness of different strategies to triage women with adnexal masses: a prospective study.
    Piovano E; Cavallero C; Fuso L; Viora E; Ferrero A; Gregori G; Grillo C; Macchi C; Mengozzi G; Mitidieri M; Pagano E; Zola P
    Ultrasound Obstet Gynecol; 2017 Sep; 50(3):395-403. PubMed ID: 27706929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinguishing cancer cell lines at a single living cell level via detection of sialic acid by dual-channel plasmonic imaging and by using a SERS-microfluidic droplet platform.
    Cong L; Liang L; Cao F; Sun D; Yue J; Xu W; Liang C; Xu S
    Mikrochim Acta; 2019 May; 186(6):367. PubMed ID: 31115772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Use of Human Epididymis 4 and Cancer Antigen 125 Tumor Markers in the Benign or Malignant Differential Diagnosis of Pelvic or Adnexal Masses.
    Dolgun ZN; Kabaca C; Karateke A; İyibozkurt C; İnan C; Altıntaş AS; Karadağ C
    Balkan Med J; 2017 Apr; 34(2):156-162. PubMed ID: 28418343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D-dimer as a tumor marker in pre-operative assessment of adnexal masses.
    Worasethsin P; Narkwichean A
    J Med Assoc Thai; 2013 Nov; 96(11):1395-400. PubMed ID: 24428087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of serum, urinary and salivary CA 125 levels in patients with adnexal masses.
    Tay SK; Chua EK
    Ann Acad Med Singap; 1994 May; 23(3):311-4. PubMed ID: 7944239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human epididymis protein 4 offers superior specificity in the differentiation of benign and malignant adnexal masses in premenopausal women.
    Holcomb K; Vucetic Z; Miller MC; Knapp RC
    Am J Obstet Gynecol; 2011 Oct; 205(4):358.e1-6. PubMed ID: 21722869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of a second-generation multivariate index assay for malignancy risk of adnexal masses.
    Coleman RL; Herzog TJ; Chan DW; Munroe DG; Pappas TC; Smith A; Zhang Z; Wolf J
    Am J Obstet Gynecol; 2016 Jul; 215(1):82.e1-82.e11. PubMed ID: 26970494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study to evaluate the risk malignancy index and its diagnostic implication in patients with suspected ovarian mass.
    Dora SK; Dandapat AB; Pande B; Hota JP
    J Ovarian Res; 2017 Aug; 10(1):55. PubMed ID: 28806987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk of malignancy index in discrimination of adnexal masses.
    Ulusoy S; Akbayir O; Numanoglu C; Ulusoy N; Odabas E; Gulkilik A
    Int J Gynaecol Obstet; 2007 Mar; 96(3):186-91. PubMed ID: 17280665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian malignancy risk stratification of the adnexal mass using a multivariate index assay.
    Bristow RE; Smith A; Zhang Z; Chan DW; Crutcher G; Fung ET; Munroe DG
    Gynecol Oncol; 2013 Feb; 128(2):252-9. PubMed ID: 23178277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doppler sonography of adnexal masses: the predictive value of the pulsatility index in benign and malignant disease.
    Salem S; White LM; Lai J
    AJR Am J Roentgenol; 1994 Nov; 163(5):1147-50. PubMed ID: 7976891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classification of asymptomatic adnexal masses by ultrasound, magnetic resonance imaging, and positron emission tomography.
    Grab D; Flock F; Stöhr I; Nüssle K; Rieber A; Fenchel S; Brambs HJ; Reske SN; Kreienberg R
    Gynecol Oncol; 2000 Jun; 77(3):454-9. PubMed ID: 10831359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative HE4, CA125 and ROMA in the differential diagnosis of benign and malignant adnexal masses.
    Terlikowska KM; Dobrzycka B; Witkowska AM; Mackowiak-Matejczyk B; Sledziewski TK; Kinalski M; Terlikowski SJ
    J Ovarian Res; 2016 Jul; 9(1):43. PubMed ID: 27436085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative C-reactive protein serum levels as a predictive diagnostic marker in patients with adnexal masses.
    Reiser E; Aust S; Seebacher V; Reinthaller A; Helmy-Bader S; Schwameis R; Grimm C; Polterauer S
    Gynecol Oncol; 2017 Dec; 147(3):690-694. PubMed ID: 28935270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discrimination between benign and malignant adnexal masses by specialist ultrasound examination versus serum CA-125.
    Van Calster B; Timmerman D; Bourne T; Testa AC; Van Holsbeke C; Domali E; Jurkovic D; Neven P; Van Huffel S; Valentin L
    J Natl Cancer Inst; 2007 Nov; 99(22):1706-14. PubMed ID: 18000221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CEA in evaluation of adnexal mass: retrospective cohort analysis and review of the literature.
    Sagi-Dain L; Lavie O; Auslander R; Sagi S
    Int J Biol Markers; 2015 Nov; 30(4):e394-400. PubMed ID: 26109367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosomal Instability in Cell-Free DNA as a Highly Specific Biomarker for Detection of Ovarian Cancer in Women with Adnexal Masses.
    Vanderstichele A; Busschaert P; Smeets D; Landolfo C; Van Nieuwenhuysen E; Leunen K; Neven P; Amant F; Mahner S; Braicu EI; Zeilinger R; Coosemans A; Timmerman D; Lambrechts D; Vergote I
    Clin Cancer Res; 2017 May; 23(9):2223-2231. PubMed ID: 27852697
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.